JP Morgan Maintains Neutral on Teladoc Health, Lowers Price Target to $19
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Lisa Gill has maintained a Neutral rating on Teladoc Health (NYSE:TDOC) but has reduced the price target from $33 to $19.
November 17, 2023 | 4:09 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
JP Morgan has maintained a Neutral rating on Teladoc Health but lowered the price target from $33 to $19, indicating a potential downside from the previous target.
The reduction in price target by a major analyst like JP Morgan can lead to a negative investor sentiment and a potential decrease in stock price in the short term, as the new target suggests a lower valuation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100